Kits Eyecare Stock Performance

KTYCF Stock  USD 13.95  0.50  3.46%   
On a scale of 0 to 100, Kits Eyecare holds a performance score of 15. The company secures a Beta (Market Risk) of 1.27, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kits Eyecare will likely underperform. Please check Kits Eyecare's expected short fall, and the relationship between the value at risk and day median price , to make a quick decision on whether Kits Eyecare's current price movements will revert.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Kits Eyecare are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Kits Eyecare reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow2.3 M
Total Cashflows From Investing Activities-3.6 M
  

Kits Eyecare Relative Risk vs. Return Landscape

If you would invest  965.00  in Kits Eyecare on November 21, 2025 and sell it today you would earn a total of  430.00  from holding Kits Eyecare or generate 44.56% return on investment over 90 days. Kits Eyecare is currently producing 0.6756% returns and takes up 3.4943% volatility of returns over 90 trading days. Put another way, 31% of traded pink sheets are less volatile than Kits, and 87% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Kits Eyecare is expected to generate 4.68 times more return on investment than the market. However, the company is 4.68 times more volatile than its market benchmark. It trades about 0.19 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.17 per unit of risk.

Kits Eyecare Target Price Odds to finish over Current Price

The tendency of Kits Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 13.95 90 days 13.95 
about 30.41
Based on a normal probability distribution, the odds of Kits Eyecare to move above the current price in 90 days from now is about 30.41 (This Kits Eyecare probability density function shows the probability of Kits Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 1.27 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Kits Eyecare will likely underperform. Additionally Kits Eyecare has an alpha of 0.4937, implying that it can generate a 0.49 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Kits Eyecare Price Density   
       Price  

Predictive Modules for Kits Eyecare

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kits Eyecare. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kits Eyecare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
10.4613.9517.44
Details
Intrinsic
Valuation
LowRealHigh
9.9113.4016.89
Details
Naive
Forecast
LowNextHigh
10.3013.8017.29
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.0014.2323.45
Details

Kits Eyecare Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Kits Eyecare is not an exception. The market had few large corrections towards the Kits Eyecare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kits Eyecare, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kits Eyecare within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.49
β
Beta against Dow Jones1.27
σ
Overall volatility
1.97
Ir
Information ratio 0.15

Kits Eyecare Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kits Eyecare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kits Eyecare can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kits Eyecare appears to be risky and price may revert if volatility continues
The company reported the revenue of 82.4 M. Net Loss for the year was (14.62 M) with profit before overhead, payroll, taxes, and interest of 20.89 M.
Kits Eyecare has accumulated about 18.89 M in cash with (19.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Roughly 77.0% of the company outstanding shares are owned by corporate insiders

Kits Eyecare Fundamentals Growth

Kits Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Kits Eyecare, and Kits Eyecare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kits Pink Sheet performance.

About Kits Eyecare Performance

By analyzing Kits Eyecare's fundamental ratios, stakeholders can gain valuable insights into Kits Eyecare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kits Eyecare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kits Eyecare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Kits Eyecare Ltd. operates a digital eyecare platform for eyes in the United States and Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. Kits Eyecare operates under Specialty Retail classification in the United States and is traded on OTC Exchange. It employs 95 people.

Things to note about Kits Eyecare performance evaluation

Checking the ongoing alerts about Kits Eyecare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Kits Eyecare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kits Eyecare appears to be risky and price may revert if volatility continues
The company reported the revenue of 82.4 M. Net Loss for the year was (14.62 M) with profit before overhead, payroll, taxes, and interest of 20.89 M.
Kits Eyecare has accumulated about 18.89 M in cash with (19.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Roughly 77.0% of the company outstanding shares are owned by corporate insiders
Evaluating Kits Eyecare's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Kits Eyecare's pink sheet performance include:
  • Analyzing Kits Eyecare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kits Eyecare's stock is overvalued or undervalued compared to its peers.
  • Examining Kits Eyecare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Kits Eyecare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kits Eyecare's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Kits Eyecare's pink sheet. These opinions can provide insight into Kits Eyecare's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Kits Eyecare's pink sheet performance is not an exact science, and many factors can impact Kits Eyecare's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Kits Pink Sheet analysis

When running Kits Eyecare's price analysis, check to measure Kits Eyecare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kits Eyecare is operating at the current time. Most of Kits Eyecare's value examination focuses on studying past and present price action to predict the probability of Kits Eyecare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kits Eyecare's price. Additionally, you may evaluate how the addition of Kits Eyecare to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stocks Directory
Find actively traded stocks across global markets